Skip to Main Content

Paper Details

A novel humanized Chi3l1 blocking antibody attenuates acetaminophen-induced liver injury in mice.
Antib Ther
1
2022
AILI, APAP, Acetaminophen, C59, C59 antibody, Chi3l1, Chi3l1-targeting antibody, acetaminophen, acute liver injury, chitinase 3-like-1, hepatic platelet, human, human Chi3l1 protein, human and mouse Chi3l1 cross-reactive mAbs, humanized, humanized C59 antibody, humanized Chi3l1 blocking antibody, kappa chain, liver injury, mice, mouse, mouse Chi3l1 proteins, rabbit, single memory B cells
Author NameAffiliation
Jason S McLellanThe University of Texas at Austin
Ningyan ZhangTexas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston
Zhiqiang AnTexas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston
  • 1 - 3

Datasets

Release 1.2